Valuation: Embecta Corp.

Market Cap 354M 317M 292M 264M 494M 33.62B 503M 3.48B 1.4B 17.69B 1.33B 1.3B 55.78B P/E 2026 *
5.28x
P/E 2027 * 4.53x
Enterprise Value 354M 317M 292M 264M 494M 33.62B 503M 3.48B 1.4B 17.69B 1.33B 1.3B 55.78B EV / Sales 2026 *
0.35x
EV / Sales 2027 * 0.33x
Free-Float
97.99%
Yield 2026 *
4.03%
Yield 2027 * 0.65%
1 day-4.73%
1 week-6.86%
1 month+10.42%
3 months+71.70%
6 months-31.69%
Current year-47.39%
1 week 6.2
Extreme 6.195
6.9
1 month 5.49
Extreme 5.49
6.9
Current year 2.77
Extreme 2.77
13.44
1 year 2.77
Extreme 2.77
14.91
3 years 2.77
Extreme 2.77
21.48
5 years 0
Extreme 0
49
10 years 0
Extreme 0
49
Manager TitleAgeSince
Chief Executive Officer 58 21/03/2022
Director of Finance/CFO 53 21/03/2022
Investor Relations Contact - 31/05/2022
Director TitleAgeSince
Chairman 58 10/02/2026
Director/Board Member 60 19/03/2022
Director/Board Member 58 31/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
04/09/26 Sell

Director

-6,293 0.0111%
12/08/26 Buy

General Counsel

20,000 0.0337%
12/08/26 Buy

Chief Financial Officer

20,000 0.0337%
Change 5-day change 1-year change 3-year change Capi.($)
-4.73%-6.86%-53.15%-58.66% 354M
+1.56%+2.41%-14.09%+12.32% 184B
-0.59%+1.18%+6.44%+36.82% 118B
-6.38%-4.98%-18.07%+8.01% 111B
+3.42%+1.71%-41.92%+8.01% 94.58B
+0.09%-0.05%-2.06%+78.69% 63.13B
-0.46%+0.42%+4.48%+82.84% 55.66B
-0.23%-0.52%+10.73%-21.72% 53.9B
-4.30%-1.64%-12.44%+37.99% 43.42B
+0.58%+2.00%-1.17%-8.82% 34.68B
Average -1.10%-0.63%-12.12%+17.55% 75.88B
Weighted average by Cap. -0.49%+0.24%-10.15%+23.71%

Financials

2026 *2027 *
Net sales 1.02B 918M 844M 765M 1.43B 97.28B 1.46B 10.06B 4.04B 51.17B 3.84B 3.76B 161B 1.08B 969M 891M 807M 1.51B 103B 1.54B 10.63B 4.27B 54.03B 4.06B 3.97B 170B
Net income 69.3M 62.07M 57.09M 51.73M 96.69M 6.58B 98.5M 681M 273M 3.46B 260M 255M 10.92B 76.83M 68.81M 63.3M 57.35M 107M 7.3B 109M 755M 303M 3.84B 288M 282M 12.1B
Net Debt - -
Projected Income Statement - Annual - Embecta Corp.
Logo Embecta Corp.
Embecta Corp. is a global medical device company. It provides solutions to improve the health and well-being of people living with diabetes. Its portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through channels, including retail, hospitals and pharmacies. It is also a manufacturer of medical devices and drug delivery technologies.
Employees
1,850
Date Price Change Volume
30/10/26 US$6.250 -4.73% 831,097
29/10/26 US$6.560 +1.55% 1,108,546
28/10/26 US$6.460 -1.37% 985,001
27/10/26 US$6.550 -3.68% 1,277,578
26/10/26 US$6.800 +1.34% 679,489
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Embecta Corp.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
6.250USD
Average target price
4.000USD
Spread / Average Target
-36.00%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Embecta Corp.
  1. Stock Market
  2. Stocks
  3. EMBC Stock